Recital 12, Directive (EU) 2026/805

In forcesince 30 Mar 2026

Substances are considered for listing in Part A of Annex I to Directive 2008/105/EC or in Annex I or Part B of Annex II to Directive 2006/118/EC based on an assessment of the risk they pose to humans and the aquatic environment. The key components of that assessment are knowledge of the environmental concentrations of the substances, including information collected from watch-list monitoring, and the (eco)toxicity of the substances, as well as their persistence, bioaccumulation, mobility, carcinogenicity, mutagenicity, reprotoxicity and endocrine-disrupting potential.